T pomoćne 17 ćelije (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "T pomoćne 17 ćelije" in Serbian language version.

refsWebsite

Global rank Serbian rank

11nih.gov

4^th place

8^th place

11doi.org

2^nd place

4^th place

doi.org

Harrington LE; Hatton RD; Mangan PR; et al. (2005). „Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages”. Nature Immunology. 6 (11): 1123—32. PMID 16200070. doi:10.1038/ni1254.
Stockinger B, Veldhoen M (2007). „Differentiation and function of Th17 T cells”. Current Opinion in Immunology. 19 (3): 281—6. PMID 17433650. doi:10.1016/j.coi.2007.04.005.
Steinman L (2007). „A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage”. Nat. Med. 13 (2): 139—45. PMID 17290272. doi:10.1038/nm1551.
Dong C (2008). „TH17 cells in development: an updated view of their molecular identity and genetic programming”. Nature Reviews Immunology. 8 (5): 337—48. PMID 18408735. doi:10.1038/nri2295.
Manel N, Unutmaz D, Littman DR (2008). „The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat”. Nature Immunology. 9 (6): 641—9. PMC 2597394 . PMID 18454151. doi:10.1038/ni.1610.
Ouyang W, Kolls JK, Zheng Y (2008). „The biological functions of T helper 17 cell effector cytokines in inflammation”. Immunity. 28 (4): 454—67. PMID 18400188. doi:10.1016/j.immuni.2008.03.004.
Bettelli E; Carrier Y; Gao W; et al. (2006). „Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells”. Nature. 441 (7090): 235—8. PMID 16648838. doi:10.1038/nature04753.
Korn T; Bettelli E; Gao W; et al. (2007). „IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells”. Nature. 448 (7152): 484—7. PMID 17581588. doi:10.1038/nature05970.
Muranski P; Boni A; Antony PA; et al. (2008). „Tumor-specific Th17-polarized cells eradicate large established melanoma”. Blood. 112 (2): 362—73. PMC 2442746 . PMID 18354038. doi:10.1182/blood-2007-11-120998.
Martin-Orozco N; Muranski P; Chung Y; et al. (2009). „T helper 17 cells promote cytotoxic T cell activation in tumor immunity”. Immunity. 31 (5): 787—98. PMC 2787786 . PMID 19879162. doi:10.1016/j.immuni.2009.09.014.
Wu S; Rhee KJ; Albesiano E; et al. (2009). „A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses”. Nature Medicine. 15 (9): 1016—22. PMID 19701202. doi:10.1038/nm.2015.

nih.gov

ncbi.nlm.nih.gov

Harrington LE; Hatton RD; Mangan PR; et al. (2005). „Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages”. Nature Immunology. 6 (11): 1123—32. PMID 16200070. doi:10.1038/ni1254.
Stockinger B, Veldhoen M (2007). „Differentiation and function of Th17 T cells”. Current Opinion in Immunology. 19 (3): 281—6. PMID 17433650. doi:10.1016/j.coi.2007.04.005.
Steinman L (2007). „A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage”. Nat. Med. 13 (2): 139—45. PMID 17290272. doi:10.1038/nm1551.
Dong C (2008). „TH17 cells in development: an updated view of their molecular identity and genetic programming”. Nature Reviews Immunology. 8 (5): 337—48. PMID 18408735. doi:10.1038/nri2295.
Manel N, Unutmaz D, Littman DR (2008). „The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat”. Nature Immunology. 9 (6): 641—9. PMC 2597394 . PMID 18454151. doi:10.1038/ni.1610.
Ouyang W, Kolls JK, Zheng Y (2008). „The biological functions of T helper 17 cell effector cytokines in inflammation”. Immunity. 28 (4): 454—67. PMID 18400188. doi:10.1016/j.immuni.2008.03.004.
Bettelli E; Carrier Y; Gao W; et al. (2006). „Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells”. Nature. 441 (7090): 235—8. PMID 16648838. doi:10.1038/nature04753.
Korn T; Bettelli E; Gao W; et al. (2007). „IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells”. Nature. 448 (7152): 484—7. PMID 17581588. doi:10.1038/nature05970.
Muranski P; Boni A; Antony PA; et al. (2008). „Tumor-specific Th17-polarized cells eradicate large established melanoma”. Blood. 112 (2): 362—73. PMC 2442746 . PMID 18354038. doi:10.1182/blood-2007-11-120998.
Martin-Orozco N; Muranski P; Chung Y; et al. (2009). „T helper 17 cells promote cytotoxic T cell activation in tumor immunity”. Immunity. 31 (5): 787—98. PMC 2787786 . PMID 19879162. doi:10.1016/j.immuni.2009.09.014.
Wu S; Rhee KJ; Albesiano E; et al. (2009). „A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses”. Nature Medicine. 15 (9): 1016—22. PMID 19701202. doi:10.1038/nm.2015.